Dr. Jeffrey Vanwormer
Claim this profileMarshfield Clinic Research Institute
Studies Obstructive Lung Diseases
Studies Chronic Obstructive Pulmonary Disease
2 reported clinical trials
3 drugs studied
Affiliated Hospitals
Clinical Trials Jeffrey Vanwormer is currently running
NuvoAir Clinical Service
for COPD
This is a 12 month study of up to 500 people with COPD to determine if the NuvoAir clinical service leads to lower rates of severe COPD exacerbations, hospitalizations, emergency room visits, and total cost of care compared to a similar group that doesn't receive care from the NuvoAir clinical service.
Recruiting1 award N/A3 criteria
Atorvastatin
for Preventing Dementia
PREVENTABLE is a multi-center, randomized, parallel group, placebo-controlled superiority study. Participants will be randomized 1:1 to atorvastatin 40 mg or placebo. This large study conducted in community-dwelling older adults without cardiovascular disease (CVD) or dementia will demonstrate the benefit of statins for reducing the primary composite of death, dementia, and persistent disability and secondary composites including mild cognitive impairment (MCI) and cardiovascular events.
Recruiting2 awards Phase 43 criteria
More about Jeffrey Vanwormer
Clinical Trial Related1 year of experience running clinical trials · Led 2 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Jeffrey Vanwormer has experience with
- NuvoAir Clinical Service
- Atorvastatin
- Placebo
Breakdown of trials Jeffrey Vanwormer has run
Obstructive Lung Diseases
Chronic Obstructive Pulmonary Disease
There is no change to this term.
Cardiovascular Disease
Mild Cognitive Impairment
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jeffrey Vanwormer specialize in?
Jeffrey Vanwormer focuses on Obstructive Lung Diseases and Chronic Obstructive Pulmonary Disease. In particular, much of their work with Obstructive Lung Diseases has involved treating patients, or patients who are undergoing treatment.
Is Jeffrey Vanwormer currently recruiting for clinical trials?
Yes, Jeffrey Vanwormer is currently recruiting for 2 clinical trials in Marshfield Wisconsin. If you're interested in participating, you should apply.
Are there any treatments that Jeffrey Vanwormer has studied deeply?
Yes, Jeffrey Vanwormer has studied treatments such as NuvoAir Clinical Service, Atorvastatin, Placebo.
What is the best way to schedule an appointment with Jeffrey Vanwormer?
Apply for one of the trials that Jeffrey Vanwormer is conducting.
What is the office address of Jeffrey Vanwormer?
The office of Jeffrey Vanwormer is located at: Marshfield Clinic Research Institute, Marshfield, Wisconsin 54449 United States. This is the address for their practice at the Marshfield Clinic Research Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.